Christopher McNulty SEC EDGAR Filings (CIK 0001701459)

SEC EDGAR filings, ownership reports, and insider transactions for Christopher McNulty.

Business address
C/O Invivo Therapeutics Holdings Corp., 1 Kendall Square, Suite B14402, Cambridge, MA, 02139
Get insider transactions for this reporting owner
Christopher McNulty has filed 11 SEC EDGAR filings since 31 Mar 2017

Latest Filings

Recent SEC filings for Christopher McNulty including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 30 Jan 2023 26 Jan 2023 001-37769
4 Open 4 document View SEC filing for 4 31 Jan 2022 27 Jan 2022 001-37769
4 Open 4 document View SEC filing for 4 29 Jan 2021 27 Jan 2021 001-37769
4 Open 4 document View SEC filing for 4 02 Jul 2020 01 Jul 2020 001-37769
4 Open 4 document View SEC filing for 4 24 Jan 2020 22 Jan 2020 001-37769
4 Open 4 document View SEC filing for 4 01 Oct 2019 01 Oct 2019 001-37769
4 Open 4 document View SEC filing for 4 04 Feb 2019 31 Jan 2019 001-37769
4 Open 4 document View SEC filing for 4 21 Sep 2018 19 Sep 2018 001-37769
3 Open 3 document View SEC filing for 3 20 Aug 2018 14 Aug 2018 001-37769
4 Open 4 document View SEC filing for 4 FORM 4 - 31 Mar 2017 29 Mar 2017 001-37350
3 Open 3 document View SEC filing for 3 FORM 3 - 31 Mar 2017 29 Mar 2017 001-37350

About this filer

Christopher McNulty files with the SEC under CIK 0001701459. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages